These findings suggest that the suppression of LDHA by FOXO3a/miR-4259 plays a critical role in mitigating LDHA-mediated cancer stemness and overcoming gemcitabine resistance in pancreatic cancer. Here, LDHA is linked to pancreatic neoplasm.